SHC orders fixing price of privately-imported COVID-19 vaccine
KARACHI: The Sindh High Court (SHC) has directed the federal government to fix the price of the COVID-19 vaccine imported by the private sector in a week. A two-member bench comprising Justice Muhammad Ali Mazhar and Justice Amjad Ali Sahito
USAID project to digitise 4.1 million DRAP records
ISLAMABAD: The USAID has handed over a Document Management System (DMS) to the Drug Regulatory Authority of Pakistan (DRAP) under the Global Health Supply Chain-Procurement and Supply Management project. “We appreciate USAID’s technology assistance in digitisation of 15 years historical
DRAP approves import of COVID-19 rapid testing kit
ISLAMABAD: Drug Regulatory Authority of Pakistan (DRAP) has formally approved the import of a rapid coronavirus testing kit. DRAP CEO Dr. Asim Rauf while confirming the registration of the coronavirus testing kit, said that the kit has been registered by
DRAP notifies hike in prices of 94 life-saving medicines
ISLAMABAD: Drug Regulatory Authority of Pakistan (DRAP) has announced to increase prices of 94 lifesaving medicines after the federal cabinet approval. DRAP on Wednesday issued a notification in this regard. The drugs prices have been jacked up include those used
DRAP reduces price of COVID-19 drug by Rs 1, 629
ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has reduced the price of remdesivir, the first and only approved treatment for Covid-19 in the United States, by Rs1,629 taking the price down to Rs 9,244. According to a notification issued
DRAP permits clinical trials of plasma therapy for COVID-19 treatment
ISLAMABAD: Special Assistant to the Prime Minister on National Health Services Dr Zafar Mirza has said Drug Regulatory Authority of Pakistan (DRAP) has permitted clinical trials of plasma therapy for coronavirus treatment. In a statement, the health adviser said the
DRAP allows 7% increase in medicines’ prices
KARACHI: The Drug Regulatory Authority of Pakistan (DRAP) has allowed a seven percent increase in the prices of medicines per year. The drug manufacturing companies have increased by seven percent as per the notification issued by the DRAP. Common medications